Published in
Esmo Open, Esmo Open, 6(5), p. e001081, 2020
DOI: 10.1136/esmoopen-2020-001081
Links
Tools
Phase I/IIa, open-label, multicentre study to evaluate the optimal dosing and safety of ODM-203 in patients with advanced or metastatic solid tumours
Journal article published in 2020 by
Petri Bono,
Christophe Massard,
Katriina J. Peltola,
Analía Azaro,
Antoine Italiano,
Rebecca S. Kristeleit,
Giuseppe Curigliano 
,
Ulrik Lassen ,
Hendrik-Tobias Arkenau,
Pasi Hakulinen,
Chris Garratt,
Tarja Ikonen,
Mika V. J. Mustonen ,
Jordi A. Rodon
,
Ulrik Lassen ,
Hendrik-Tobias Arkenau,
Pasi Hakulinen,
Chris Garratt,
Tarja Ikonen,
Mika V. J. Mustonen ,
Jordi A. Rodon
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Data provided by 